August 10, 2017 SET-17-AC-003 Dear The President The Stock Exchange of Thailand Subject: Clarification of Result’s Operation for three months periods ended 30 June 2017 According to the resolution of
August 10, 2018 SET-18-AC-002 Dear The President The Stock Exchange of Thailand Subject: Clarification of Result’s Operation for the three months ended 30 June 2018 According to the resolution of
) million, decreased for THB 97.71 million or 207.89% comparing to the 2nd quarter ended as of June 30, 2016, which the realized net profit for THB 47.00 million, for the following reasons; Revenue The
Page 1 of 4 No. RJH – SET 16/2019 11 November 2019 Subject : Management’s Discussion and Analysis for the 3rd Quarter of 2019 To : The President The Stock Exchange of Thailand Rajthanee Hospital
August 11, 2020 Subject: Management’s Discussion and Analysis for the second Quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries
โทรสาร (043) 236-835 456 Moo 14 Mittraparp Rd. Muang Khon Kaen Thailand 40000 Tel. (043) 333-555 Fax. (043) 236-835 Ratchaphruek Hospital No. RPH-SET 11/2019 November 7, 2019 Subject : Management
follows: The company has total revenue of THB 7.96 million for the second quarter 2017, decrease by THB 13.02million or 98.91% when compared to the second quarter 2016, by reducing Non-performing debt
force to accommodate both public and private sectors to set up infrastructure funds. Currently, three sizable infrastructure funds investing in rail transportation, electricity, and telecommunication have
) Million baht Million baht Million baht % Total revenue 444.51 501.45 (56.94) (11.36) Cost of sales and services (428.19) (577.56) (149.37) (25.86) Sales and Administration Expenses and Financial cost (21.41
“Company”) would like to provide the clarification on the business operation for the 3rd Quarter of the year 2017 ended 30 September 2017. The Company set up a subsidiary company, which registered as a